Glenmark Pharmaceuticals

Rediff.com » News » Glenmark Pharmaceuticals

News for Glenmark Pharmaceuticals

News
Business

Why Is USFDA Inspecting India Pharma Firms?

Kindly note the image has been posted only for representational purposes.Photograph: Kind courtesy Pixabay.com The Indian pharmaceutical industry's recent tryst with the US drug regulator......

First nasal spray for treating Covid patients launched in India

Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering......

Drug to treat mild, moderate COVID-19 launched in India

Drug firm Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a price......

Pharma majors shift focus to inhalants, nasal spray for Covid

While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus......

With Covid surge, FabiFlu becomes most sold drug in India

Drugs that are used to treat Covid or used by people as immunity boosters have seen a jump in sales and, in turn, rankings, reports Sohini Das. IMAGE: A chemist displays the Fabiflu......

Diabetes Drug Price Drops 90%

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 crore anti-diabetic drug market in India is growing at 9 per cent or so.......

Mutual Funds Emerge As Financiers For M&A Deals

'Growth for some companies has been hard to come by and this is a smart way to get there.' Illustration: Dominic Xavier/Rediff.com Companies are increasingly turning to mutual funds to help......

618 Drugs 'Not Of Standard Quality'

Among the commonly used analgesic formulations (painkillers) found NSQ are combinations of paracetamol with ibuprofen, diclofenac and mefenamic acid.Medications using these combinations are......

Glenmark to sell 75% in life sciences arm to Nirma for Rs 5,651.5 cr

Glenmark Pharmaceuticals on Thursday said it will sell a 75 per cent stake in its subsidiary Glenmark Life Sciences to Nirma Ltd for Rs 5,651.5 crore. Photograph: PTI Photo from the Rediff......

MNCs look towards India for a booster dose

In recent months, several pharma multinational corporations (MNCs) are increasingly turning to Indian companies to expand market reach in the country’s pharmaceuticals sector. Illustration:......

Rediff News

Glenmark Pharmaceuticals

News for Glenmark Pharmaceuticals

Why Is USFDA Inspecting India Pharma Firms?

First nasal spray for treating Covid patients launched in India

Drug to treat mild, moderate COVID-19 launched in India

Pharma majors shift focus to inhalants, nasal spray for Covid

With Covid surge, FabiFlu becomes most sold drug in India

Diabetes Drug Price Drops 90%

Mutual Funds Emerge As Financiers For M&A Deals

618 Drugs 'Not Of Standard Quality'

Glenmark to sell 75% in life sciences arm to Nirma for Rs 5,651.5 cr

MNCs look towards India for a booster dose

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS